Clinical Trials Logo

Clinical Trial Summary

Recommendations for carbohydrate intakes in the pre-exercise meal for endurance athletes are available; however, are lacking protein. Therefore, the purpose of this study is to quantify exercise-induced gastrointestinal symptoms and gut fullness occurring in response to a low protein (control) and a high protein (intervention) pre-exercise meal. The secondary purpose is to quantify blood glucose responses to a high-protein pre-exercise meal as compared to a low-protein control.


Clinical Trial Description

Context: Proper nutrition is crucial for peak sport performance. Recommendations for carbohydrate intakes in the pre-exercise meal for endurance athletes are available; however, are lacking for protein. Furthermore, a recent position statement regarding nutrient timing for exercise also lacks protein recommendations. The only advice provided is to avoid "too much" as it may cause gastrointestinal (GI) discomfort. The aforementioned recommendation provides no guidance as to how much is "too much" nor, to our knowledge, is there any clinical trial data to support the position. Exercise-associated gastrointestinal symptoms are a common cause of withdrawal from competition; thus, athletes need to consider the impact of dietary choices on gastrointestinal (GI) symptoms, as well as performance. Exercise induced GI symptoms can plague all athletes; but the effects seem to be most pronounced in endurance running. The reported prevalence of exercise-induced GI disturbances varies depending on methodology; however a questionnaire administered by the investigator's lab to 440 runners found 41% experienced stomach pain/cramps, 24% had intestinal issues, and over 20% reported bloating, diarrhea and/or gas. Exercise related GI complaints have been broadly related to diet. Research from the investigator's lab has found that many of the top foods that are avoided pre-running, to reduce GI symptoms, are those classified as high in protein (legumes, meat, poultry, fish, milk). These observations are based on self-reported data from experienced runners, and require testing in a clinical setting. Objectives: 1) to quantify exercise induced gastrointestinal symptoms and gut fullness occurring in response to a low protein (control) and high protein (intervention) pre-exercise meal. 2) to quantify blood glucose responses to a high protein pre-exercise meal as compared to a low protein control. Methods: The study is a single blind crossover design. Endurance runners will be ask to standardize their exercise 3-days prior to testing. The participants will be asked to eat a similar meal in the 24-12 hours pre-testing and fast for 12 hours pre-testing. The participants will be assigned to consume a pre-exercise shake with carbohydrate at 0.75g/kg body weight + water at 5ml/kg body weight and either low whey protein control or high whey protein intervention one hour pre-exercise in a randomized fashion. Participants will then complete a 10 km running protocol at 85% of the participant's race pace on a treadmill in an temperature and humidity controlled room. Gastrointestinal symptoms via self-report questionnaire and blood glucose will be measured at fasting, during the one hour digestive period and post-exercise. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05855174
Study type Interventional
Source Mount Royal University
Contact
Status Completed
Phase N/A
Start date March 13, 2019
Completion date December 21, 2023

See also
  Status Clinical Trial Phase
Completed NCT04032262 - Parkinson's Disease and Digestive Health N/A
Recruiting NCT06092866 - Digital Versus Telephone Symptom Assessment and Triage in Primary Care N/A
Not yet recruiting NCT05553717 - Clinical Study Evaluating the Gastroprotective Effect of Carvedilol in Patients With Ischemic Heart Disease on Aspirin Therapy N/A
Recruiting NCT05627882 - Evaluation of the Impact of a Forward Viewing Scope at Time of ERCP
Recruiting NCT05159921 - Can the SurgInfoBot Improve the Consent Process for Endoscopy? A Randomised Controlled Trial N/A
Active, not recruiting NCT04182633 - MTT for Children With ASD Who Have Gastrointestinal Disorders Phase 2
Not yet recruiting NCT05846802 - Gastroparesis Registry 4
Enrolling by invitation NCT05889806 - AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)
Enrolling by invitation NCT05249270 - Online Parent-Report Evaluation of the Effects of Processed Music
Completed NCT03675763 - Efficacy of a Craniosacral Therapy Protocol in the Treatment of Infant Colic N/A
Recruiting NCT05371067 - Fructose Effect on Neuroinflammation and Feelings N/A
Completed NCT05200325 - Clinical Utility Evidence for TissueCypher® N/A
Active, not recruiting NCT05470387 - A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection Phase 3
Recruiting NCT05874726 - Biological Sample Repository for Gastrointestinal Disorders
Completed NCT06157034 - Prokinetic Effect of Selected Nutraceuticals N/A
Recruiting NCT04085211 - Image-Enhanced Endoscopy in the Gastrointestinal Tract
Active, not recruiting NCT04293653 - Protocol for Patients Above 75 Years Undergoing Emergency Laparotomy N/A
Withdrawn NCT03884400 - Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
Recruiting NCT04084249 - IMPROVE-IT2: ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial N/A
Completed NCT04213833 - Effect of Palatable Lidocaine Gel on Gag Reflex for Patients Undergoing Upper Gastrointestinal Endoscopy N/A